Should young kids take the new anti-obesity drugs? What the research says - Nature
Clinical trials show GLP-1 mimics like liraglutide and semaglutide help children and adolescents lose weight, but long-term effects on growth and puberty are unknown. Experts debate the ethical implications and effectiveness of using BMI as a metric, emphasizing the need for more diverse studies and prolonged monitoring.
Reference News
Should young kids take the new anti-obesity drugs? What the research says - Nature
Clinical trials show GLP-1 mimics like liraglutide and semaglutide help children and adolescents lose weight, but long-term effects on growth and puberty are unknown. Experts debate the ethical implications and effectiveness of using BMI as a metric, emphasizing the need for more diverse studies and prolonged monitoring.